Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$29.84−1.49 (-4.76%)
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
Oscar Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Oscar Health's price to sales ratio was 0.6× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.1× to 1.0×, with a median of 0.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | +0.3 |
| 2025 | Dec 31, 2025 | 0.3× | −0.1 |
| 2024 | Dec 31, 2024 | 0.4× | +0.1 |
| 2023 | Dec 29, 2023 | 0.4× | +0.2 |
| 2022 | Dec 30, 2022 | 0.1× | −0.5 |
| 2021 | Dec 31, 2021 | 0.7× | – |
See a number that looks wrong?